CRH 8-K Filed 2026-07-30 Execution disclosure

CRH pauses share buybacks ahead of $8.5B Arcosa acquisition

Company repurchased $0.7B year-to-date but halted new tranches pending deal close in Q1 2027

Shares repurchased2.5M
Avg price paid$120.00
MechanismNot specified

What the filing says

CRH repurchased approximately 2.5 million ordinary shares for $0.3 billion in the second quarter of 2026, bringing year-to-date repurchases to $0.7 billion as of July 28, 2026. The execution mechanism is not specified in the filing.

On June 22, 2026, concurrent with CRH's announcement of its definitive agreement to acquire Arcosa Inc. for $8.5 billion, the company stated that it has not initiated a new tranche of its share buyback program. CRH noted it will reevaluate the buyback program at a later date, subject to market conditions, balance sheet strength, capital allocation priorities and other factors.

The company's balance sheet shows net debt of $15.4 billion as of June 30, 2026, up from $14.2 billion at year-end 2025. CRH has secured a $5.8 billion bridge facility to help finance the Arcosa acquisition, which is expected to close in Q1 2027 subject to regulatory approval and other customary conditions.

CRH's pause of new buyback tranches reflects the substantial capital commitment required for the Arcosa acquisition and the company's stated focus on maintaining a strong balance sheet and investment-grade credit rating. The $0.7 billion in year-to-date buybacks represent a reduction from prior-year activity, as the company manages capital allocation around near-term M&A. The reprieve does not constitute a formal termination of the buyback program; rather, it is a temporary halt while CRH finances and integrates a major acquisition. Once the Arcosa deal closes and the company's capital structure stabilizes, buyback activity could resume.
As part of its share buyback program, in the three months ended June 30, 2026, CRH repurchased approximately 2.5 million Ordinary Shares for a total consideration of $0.3 billion, compared to 3.7 million Ordinary Shares repurchased for a total consideration of $0.3 billion in the three months ended June 30, 2025. On July 28, 2026, the latest tranche of the share buyback program was completed, bringing the year-to-date repurchases to $0.7 billion. As announced on June 22, 2026, in connection with the agreement to acquire Arcosa, CRH has not initiated a new tranche of its share buyback program. — CRH PUBLIC LTD CO 8-K filing  ·  View on SEC EDGAR →

What this means

Frequently asked questions

Why did CRH pause its share buyback program?
CRH suspended new buyback tranches on June 22, 2026, in connection with its agreement to acquire Arcosa Inc. for $8.5 billion. The company is prioritizing balance sheet strength and capital allocation toward the acquisition, which is expected to close in Q1 2027.
How many shares did CRH repurchase in Q2 2026?
CRH repurchased approximately 2.5 million ordinary shares for $0.3 billion in Q2 2026. Year-to-date repurchases totaled $0.7 billion through July 28, 2026, when the latest tranche was completed.
What is CRH's net debt position?
Net debt was $15.4 billion as of June 30, 2026, up from $14.2 billion at December 31, 2025. CRH secured a $5.8 billion bridge facility to partially finance the Arcosa acquisition and refinance certain Arcosa debt.
When will CRH resume buybacks?
CRH stated it will reevaluate its buyback program at a later date, subject to market conditions, balance sheet strength, capital allocation priorities and other factors. No specific timeline was provided in the filing.
How does the buyback pause compare to prior-year activity?
Q2 2026 repurchases of $0.3 billion were flat versus Q2 2025, but the company deployed less capital into buybacks overall to preserve liquidity for the Arcosa deal. Year-to-date 2026 buybacks of $0.7 billion represent a deliberate moderation of the program.
execution mega-cap buyback-pause m-a-activity balance-sheet-management infrastructure-sector
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.